title: Investigation of changes in apelin receptor mRNA and protein expression in the myocardium and aorta of rats with two-kidney, one-clip (2K1C) Goldblatt hypertension.
abstract: Experimental and clinical evidences suggest that apelin and its receptor APJ are involved in the pathogenesis of cardiovascular complications. However, the role of apelin/APJ in hypertension is not sufficiently understood. Because chronic kidney diseases lead to hypertension and cardiac failure, we investigated the changes in apelin receptor gene expression in the myocardium and aorta of rat models of kidney disease hypertension. Two-kidney, one-clip (2K1C) hypertension was produced by placing a clip around the renal artery. Four and 16 weeks later, blood pressure, left ventricular end-diastolic pressure (LVEDP), serum apelin, and angiotensin II were measured. The messenger RNA (mRNA) and protein of APJ were determined by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. Chronic hypertensive rats had approximately 10 times higher LVEDP (P < 0.001). 2K1C decreased serum apelin from 220 ± 11 to 170 ± 10 pg/mL in 16 weeks (P < 0.05). The mRNA expression of APJ significantly decreased in the heart and aorta at 4 weeks. At 16 weeks, the reduction was not significant in the heart but was significant in the aorta. At 4 weeks, the expression of the APJ protein significantly decreased in the heart but not in the aorta. At 16 weeks, APJ protein was significantly decreased only in the aorta. Reduction of serum apelin and downregulation of apelin receptors in both the heart and aorta may play a role in the pathophysiology of hypertension and cardiac failure in 2K1C hypertensive rats.
authors.affiliation: Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran, najafipourh@kmu.ac.ir.
authors.forename: Hamid
authors.initials: H
authors.lastname: Najafipour
authors.forename: Abedin
authors.initials: A
authors.lastname: Vakili
authors.forename: Beydolah
authors.initials: B
authors.lastname: Shahouzehi
authors.forename: Ava
authors.initials: A
authors.lastname: Soltani Hekmat
authors.forename: Yaser
authors.initials: Y
authors.lastname: Masoomi
authors.forename: Mahbobeh
authors.initials: M
authors.lastname: Yeganeh Hajahmadi
authors.forename: Saeed
authors.initials: S
authors.lastname: Esmaeli-Mahani
mesh_terms: D000804:Angiotensin II / Q000097:blood / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001011:Aorta / Q000378:metabolism / Q000503:physiopathology; D000073861:Apelin; D000075244:Apelin Receptors; D001794:Blood Pressure / Q000235:genetics; D004195:Disease Models, Animal; D006333:Heart Failure / Q000235:genetics; D006352:Heart Ventricles / Q000503:physiopathology; D006978:Hypertension, Renovascular / Q000235:genetics* / Q000503:physiopathology; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood; D007668:Kidney / Q000503:physiopathology / Q000601:surgery; D008297:Male; D009206:Myocardium / Q000378:metabolism; D017207:Rats, Sprague-Dawley; D043562:Receptors, G-Protein-Coupled / Q000235:genetics* / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013525:Surgical Instruments
chemical_list: D000073861:Apelin; D000075244:Apelin Receptors; C498579:Apln protein, rat; C491284:Aplnr protein, rat; D036341:Intercellular Signaling Peptides and Proteins; D043562:Receptors, G-Protein-Coupled; D000804:Angiotensin II